Literature DB >> 8491450

Changes in type IV collagen content in livers of patients with alcoholic liver disease.

M Tsutsumi1, S Urashima, Y Matsuda, S Takase, A Takada.   

Abstract

An increase of serum type IV collagen levels in patients with liver disease has been reported; however, the mechanisms of this increase are not yet well known. We recently developed an assay system for type IV collagen content in liver biopsy specimens. In this study, type IV collagen content in the livers and sera of patients with alcoholic liver disease and nonalcoholic liver disease was determined. Serum and hepatic type IV collagen contents were measured with a one-step sandwich enzyme immunoassay system using monoclonal antibodies for human type IV collagen. Hepatic type IV collagen content increased significantly in liver disease. In alcoholic liver disease, type IV collagen content in patients with mild fibrosis was lower than that in advanced types of alcoholic liver disease. In nonalcoholic liver disease, hepatic type IV collagen content tended to increase with the progression of fibrosis. Type IV collagen content in alcoholic liver disease was significantly higher than that in the corresponding type of nonalcoholic liver disease. Hepatic total collagen content increased significantly in parallel with the progression of fibrosis in both alcoholic liver disease and nonalcoholic liver disease. The total collagen content in each type of alcoholic liver disease was significantly lower than that in the corresponding type of nonalcoholic liver disease. The ratio of type IV collagen to total collagen content was the highest in livers showing mild fibrosis, both in alcoholic liver disease and nonalcoholic liver disease, and decreased in parallel with the progression of fibrosis. The ratio in patients with alcoholic liver disease was significantly higher than that in those with the corresponding nonalcoholic liver disease.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8491450

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  8 in total

1.  Centrizonal arteries and microvessels in nonalcoholic steatohepatitis.

Authors:  Ryan M Gill; Patricia Belt; Laura Wilson; Nathan M Bass; Linda D Ferrell
Journal:  Am J Surg Pathol       Date:  2011-09       Impact factor: 6.394

2.  Progress in non-invasive detection of liver fibrosis.

Authors:  Chengxi Li; Rentao Li; Wei Zhang
Journal:  Cancer Biol Med       Date:  2018-05       Impact factor: 4.248

3.  Serum type IV collagen in various liver diseases in comparison with serum 7S collagen, laminin, and type III procollagen peptide.

Authors:  C Hirayama; H Suzuki; A Takada; K Fujisawa; K Tanikawa; S Igarashi
Journal:  J Gastroenterol       Date:  1996-04       Impact factor: 7.527

4.  Role of α1 and α2 chains of type IV collagen in early fibrotic lesions of idiopathic interstitial pneumonias and migration of lung fibroblasts.

Authors:  Hirokazu Urushiyama; Yasuhiro Terasaki; Shinya Nagasaka; Mika Terasaki; Shinobu Kunugi; Takahide Nagase; Yuh Fukuda; Akira Shimizu
Journal:  Lab Invest       Date:  2015-05-25       Impact factor: 5.662

5.  Noninvasive determination of liver collagen content in chronic hepatitis. Multivariate regression modeling with blood chemical parameters as variables.

Authors:  S Takamatsu; H Nakabayashi; Y Okamoto; H Nakano
Journal:  J Gastroenterol       Date:  1997-06       Impact factor: 7.527

6.  Contribution of Streptococcus mutans Strains with Collagen-Binding Proteins in the Presence of Serum to the Pathogenesis of Infective Endocarditis.

Authors:  Masatoshi Otsugu; Ryota Nomura; Saaya Matayoshi; Noboru Teramoto; Kazuhiko Nakano
Journal:  Infect Immun       Date:  2017-11-17       Impact factor: 3.441

7.  The cyclic pattern of blood alcohol levels during continuous ethanol feeding in rats: the effect of feeding S-adenosylmethionine.

Authors:  F Bardag-Gorce; J Li; J Oliva; S C Lu; B A French; S W French
Journal:  Exp Mol Pathol       Date:  2010-03-17       Impact factor: 3.362

8.  Clinical Benefits of Biochemical Markers of Fibrosis in Egyptian Children With Chronic Liver Diseases.

Authors:  Tawhida Y Abdel-Ghaffar; Behairy E Behairy; Azza Abd El-Shaheed; Karam Mahdy; Mohamed El-Batanony; Mohsen H Hussein; Mostafa M Sira
Journal:  Gastroenterology Res       Date:  2010-11-20
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.